Ditchcarbon
  • Contact
  1. Organizations
  2. NextWave Pharmaceuticals, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 22 days ago

NextWave Pharmaceuticals, Inc. Sustainability Profile

Company website

NextWave Pharmaceuticals, Inc., a leading player in the pharmaceutical industry, is headquartered in the United States and operates across key regions globally. Founded in 2005, the company has made significant strides in developing innovative therapies, particularly in the fields of neurology and pain management. NextWave is renowned for its unique product offerings, including specialised formulations that address unmet medical needs, setting it apart from competitors. With a strong commitment to research and development, the company has achieved notable milestones, including successful product launches and strategic partnerships that enhance its market position. As a trusted name in pharmaceuticals, NextWave Pharmaceuticals continues to focus on delivering high-quality, effective solutions that improve patient outcomes and drive advancements in healthcare.

DitchCarbon Score

How does NextWave Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

NextWave Pharmaceuticals, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.

29%

Let us know if this data was useful to you

NextWave Pharmaceuticals, Inc.'s reported carbon emissions

NextWave Pharmaceuticals, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data, including specific figures for Scope 1, 2, or 3 emissions. As a current subsidiary, it does not inherit emissions data from a parent company, and there are no documented reduction targets or climate pledges associated with its operations. In the absence of specific emissions data, it is important to note that NextWave Pharmaceuticals, Inc. is part of an industry increasingly focused on sustainability and climate commitments. Many companies in the pharmaceutical sector are adopting science-based targets and engaging in initiatives to reduce their carbon footprint. However, without specific commitments or data from NextWave Pharmaceuticals, it is unclear how they align with these industry trends. As the company continues to develop its sustainability strategy, stakeholders may look for future disclosures regarding emissions and climate initiatives to better understand its environmental impact and commitments.

How Carbon Intensive is NextWave Pharmaceuticals, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. NextWave Pharmaceuticals, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is NextWave Pharmaceuticals, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for NextWave Pharmaceuticals, Inc. is in US, which has a low grid carbon intensity relative to other regions.

NextWave Pharmaceuticals, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

NextWave Pharmaceuticals, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare NextWave Pharmaceuticals, Inc.'s Emissions with Industry Peers

Shionogi Pharma, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251106.5
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy